HI homepage

Emergency Department room ED ER EM

Headaches are a common complaint among patients presenting to the emergency department, with millions of cases documented annually in the United States. 

AI healthcare doctor surgery procedure artificial intelligence

The program provides detailed assessments of how algorithms implemented into workflows are impacting efficiency and outcomes. 

Arlene Sussman, MD, radiologist-medical director, mammography, at vRad, explains a telebreast imaging system that allows patients direct video consults with their remote radiologist just after their exams to increase personalized care and to answer questions immediately to avoid waiting for answers. She spoke on this technology in sessions at RSNA 2024.

Arlene Sussman, MD, medical director with vRad, explains a telebreast imaging system that allows patients direct video consults with a remote radiologist just after their exams to increase personalized care and answer questions immediately.

 

handcuffs arrested arrest jail

Investigators say the doctor “committed sexual acts with almost all the women who entered his office alone."

Experts use radiomics features to spot specific tissue patterns related to breast cancer.

These findings could be beneficial for women with dense breasts, which increase the risk of developing cancer while making it significantly more difficult to detect. 

GE HealthCare Optison ultrasound enhancing agent used to enhance otherwise suboptimal echocardiograms and better show the borders of the chambers of the heart.

Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997.

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.